Home › Leucemia linfoblastica acuta › California › Los Angeles
Studi clinici su Leucemia linfoblastica acuta a Los Angeles, CA
14 studi su Leucemia linfoblastica acuta cercano partecipanti presso sedi a Los Angeles e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
In reclutamento
- Children's Hospital of Los Angeles, Los Angeles
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
In reclutamentoFase 2
- Children's Hospital Los Angeles, Los Angeles
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
In reclutamentoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
In reclutamentoFase 2
- Children's Hospital Los Angeles, Los Angeles
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
In reclutamentoStudio osservazionale
- University of California Los Angeles, Los Angeles
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
In reclutamentoFase 1
- Cedars-Sinai Medical Center, Los Angeles
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
In reclutamentoStudio osservazionale
- UCLA, Los Angeles
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
In reclutamentoFase 1/2
- Children's Hospital Los Angeles, Los Angeles
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
In reclutamentoStudio osservazionale
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
In reclutamentoFase 3
- Ascentage Investigative Site #1134, Los Angeles
- Ascentage Investigative Site #1059, Los Angeles
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
In reclutamentoFase 2
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Bright Ideas - CIN Feasibility Study
In reclutamento
- Children's Hospital Los Angeles, Los Angeles
Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy
In reclutamento
- Jackie and Gene Autry Orthopedic Center, CHLA, Los Angeles
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
In reclutamentoFase 1
- Children's Hospital Los Angeles, Los Angeles
Studi su Leucemia linfoblastica acuta in altre città
- Houston, TX28 studi
- New York City, NY24 studi
- Baldwin Park, CA21 studi
- Seattle, WA21 studi
- Chicago, IL19 studi
- Atlanta, GA19 studi
- Memphis, TN16 studi
- Philadelphia, PA16 studi
- Washington, DC16 studi
- Boston, MA15 studi
- Durham, NC13 studi
- Mountain View, CA13 studi
Altri studi a Los Angeles
- Cancro del polmone non a piccole cellule87 studi
- Cancro (tutti i tipi)73 studi
- Cancro al seno72 studi
- Cancro alla prostata61 studi
- Cancro colorettale59 studi
- Cancro metastatico57 studi
- Cancro ovarico50 studi
- Cancro ai polmoni45 studi
- Carcinoma a cellule squamose della testa e del collo42 studi
- Cancro pancreatico35 studi
- Cancro dell'endometrio34 studi
- Melanoma34 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.